Showing results (281-290 of 831) with videos related to
Sort By:
Pageof 84
Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Diabetes Care|July 28, 2004
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal diseaseAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.Kidney International. Supplement|December 23, 2004
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuriaAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.Kidney International|April 4, 2017
Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetesAndrzej S Krolewski, Jan Skupien, Peter Rossing, et al.Journal of Diabetes and Its Complications|March 6, 2016
Self-reported dyspnea is associated with impaired global longitudinal strain in ambulatory type 1 diabetes patients with normal ejection fraction and without known heart disease - The Thousand & 1 StudyMagnus Thorsten Jensen, Niels Risum, Peter Rossing, et al.BMJ Open Diabetes Research & Care|February 11, 2026
Feasibility and cost-effectiveness of at-home self-sampling screening for type 2 diabetes: a pilot screening study in DenmarkNuri Cayuelas Mateu, Peter Rossing, Kirsten Piepgras Neergaard, et al.Diabetes Care|June 29, 2021
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD TrialFrederik Persson, Peter Rossing, Priya Vart, et al.Acta Diabetologica|October 18, 2017
Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 StudySimone Theilade, Peter Rossing, Jan S Jensen, et al.Methods in Molecular Biology (Clifton, N.J.)|November 9, 2019
Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic NephropathyJustyna Siwy, Linda Ahonen, Pedro Magalhães, et al.Pageof 84